The recent withdrawal from development of Pfizer’s torcetrapib sparked yet more discussion around the impact that such an event has on the industry. It is yet to predict whether torcetrapib’s withdrawal will have a similar impact on Pfizer’s competitors. Possible solutions to drug withdrawals and other problems have been touted and also the steps to minimize the recurrence of drugs withdrawals.